A Paradigm for Gene Regulation: Inflammation, NF-κB and PPAR
The DOI matches its Crossref record; 108 of the 109 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
The onset of inflammatory gene expression is driven by the transcription factor NF-kappaB, whose transcriptional activity is regulated at multiple levels. First, NF-kappaB activity is regulated by cytoplasmic degradation of the IkappaB inhibitor and nuclear translocation. Second, the nuclear p65 transactivation potential can be further influenced by posttranslational modifications, such as phosphorylation and/or acetylation. The p65 phosphorylation is a process highly regulated by both cell- and stimulus-dependent activating kinases. Ser276 phosphorylation seems to be highly important considering its crucial role in the interaction with and the engagement of the cofactor CBP/p300. We have identified MSK1 as an acting kinase in the TNF-signalling pathway, where it is responsible for p65 phosphorylation at Ser276, as well as for H3 phosphorylation of Ser10 in IL-6 promoter-associated chromatin (Fig. 1) (Saccani et al., 2002; Vermeulen et al., 2002, 2003). To our knowledge, this was the first report that identifies one particular kinase involved in transcription factor phosphorylation and histone modification at the level of a single promoter in order to establish gene activation. The question of which element takes the initial step to recruit and to assemble the activated transcription complex still remains unanswered (Vanden Berghe et al., 2002). PPAR alpha negatively interferes with inflammatory gene expression by up-regulation of the cytoplasmic inhibitor molecule IkappaB alpha, thus establishing an autoregulatory loop (Fig. 1). This induction takes place in the absence of a PPRE, but requires the presence of NF-kappaB and Sp1 elements in the IkappaB alpha promoter sequence as well as DRIP250 cofactors. The detailed mechanism how PPAR can activate genes in a non-DNA-binding way needs further investigation; moreover, it is at present not clear whether this upregulation, unlike the inhibitory effect of glucocorticoids, is a cell type- or a PPAR-specific phenomenon.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The reduction in NF-κB pathway activation is thought to be caused by an up-regulation in PPARγ activity, which is known to interfere with NF-κB activation [154].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [154]
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Tumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359
Research works printed but not linked: 21
- Delerive, P., Gervois, P., Fruchart, J. C, and Staels, B., 2000, Induction of IkBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-a activators.J. Biol. Chem.275:36703–36707. · DOI · Paper page
- Deng, W. G., Zhu, Y., and Wu, K. K., 2003, Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-a-induced cyclooxygenase-2 promoter activation.J. Biol. Chem.278:4770–4777. · DOI · Paper page
- Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., and Wahli, W., 1996, The PPARa-leukotriene B4 pathway to inflammation control.Nature384:39–43. · DOI · Paper page
- Dixit, V., and Mak, T. W., 2002, NF-kB signaling. Many roads lead to Madrid.Cell111:615–619. · DOI · Paper page
- El Kharroubi, A., Piras, G., Zensen, R., and Martin, M. A., 1998, Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter.Mol. Cell. Biol.18:2535–2544. · DOI
- Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., and Collins, T., 1997, CREB- binding protein/p300 are transcriptional coactivators of p65.Proc. Natl. Acad. Sci. USA94:2927–2932. · DOI · Paper page
- Ghosh, S., and Karin, M., 2002, Missing pieces in the NF-kB puzzle.Cell109:S81–96. · DOI · Paper page
- Giles, R. H., Peters, D. J., and Breuning, M. H., 1998, Conjunction dysfunction: CBP/p300 in human disease.Trends Genet.14:178–183. · DOI · Paper page
- Gilmore, T. D., 1999, The Rel/NF-KB signal transduction pathway: introduction.Oncogene18:6842–6844. · DOI · Paper page
- Glass, C. K., and Rosenfeld, M. G., 2000, The coregulator exchange in transcriptional functions of nuclear receptors.Genes Dev.14:121–141. · DOI · Paper page
- Gu, W., and Roeder, R. G., 1997, Activation of p53 sequence-specific DNA binding by acetyl-ation of the p53 C-terminal domain.Cell90:595–606. · DOI · Paper page
- Hampsey, M., and Reinberg, D., 1999, RNA polymerase II as a control panel for multiple coactivator complexes. Curr. Opin. Genet. Dev.9:132–139. · DOI
- Heyninck, K., De Valck, D., Vanden Berghe, W., Van Criekinge, W., Contreras, R., Fiers, W., Haegeman, G., and Beyaert, R., 1999, The zinc finger protein A20 inhibits TNF-induced NF- KB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-KB-inhibiting protein ABIN.J. Cell Biol.145:1471–1482. · DOI · Paper page
- Holloway, A. F., Rao, S., Chen, X., and Shannon, M. F., 2003, Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor kB proteins.J. Exp. Med.197:413–423. · DOI
- Hong, S. H., Wong, C. W., and Privalsky, M. L., 1998, Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressorMol. Endocrinol. 12:1161–1171. · DOI · Paper page
- Huang, T. T., Kudo, N., Yoshida, M, and Miyamoto, S., 2000, A nuclear export signal in the N- terminal regulatory domain of IkBoc controls cytoplasmic localization of inactive NF-KB/IicBa complexes.Proc. Nad. Acad. Sci. USA97:1014–1019. · DOI · Paper page
- Dceda, K., Steger, D. J., Eberharter, A., and Workman, J. L., 1999, Activation domain-specific and general transcription stimulation by native histone acetyltransferase complexes Mol. Cell. Biol. 19:855–863. · DOI
- Israel, A., 2000, The IKK complex: an integrator of all signals that activate NF-kB?Trends Cell Biol.10:129–133. · DOI · Paper page
- Ito, C. Y., Kazantsev, A. G., and Baldwin, A. S., 1994, Three NF-kB sites in the IkB-o, promoter are required for induction of gene expression by TNF a.Nucleic Acids Res.22: 3787–3792. · DOI · Paper page
- Jacobson, S., and Pillus, L., 1999, Modifying chromatin and concepts of cancer.Curr. Opin. Genet. Dev.9:175–184. · DOI
- Wajant, H., Pfizenmaier, K., and Scheurich, P., 2003, Tumor necrosis factor signaling. Cell Death Differ. 10,45–65. · DOI · Paper page
Cited by
Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance
Calder, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.010 · Cited by 1,717
Omega‐3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?
Calder, P. C. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04374.x · Cited by 1,347
Omega-3 Fatty Acids and Inflammatory Processes
Calder, P. C. (2010) · Nutrients · doi:10.3390/nu2030355 · Cited by 1,116
Dietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
Peroxisome Proliferator-Activated Receptor Alpha Target Genes
Rakhshandehroo, M., Knoch, B., Müller, M., & Kersten, S. (2010) · PPAR Research · doi:10.1155/2010/612089 · Cited by 1,020
Metadata
- Authors
- Vanden Berghe, W., Vermeulen, L., Delerive, P., De Bosscher, K., Staels, B., & Haegeman, G.
- Affiliations
- Ghent University (BE)
- Inserm (FR)
- Venue
- Advances in experimental medicine and biology
- Publisher
- Springer US
- Published
- 2003
- Volume
- 544
- Pages
- 181-196
- ISSN
- 0065-2598 (ISSN-L)
- OpenAlex
- W1506249422
- Cited by
- 222
- References
- 105
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 5 · 2023: 8 · 2022: 5 · 2021: 14 · 2020: 17 · 2019: 8 · 2018: 7 · 2017: 9 · 2016: 9 · 2015: 11 · 2014: 12 · 2013: 17 · 2012: 15
- FWCI
- 4.51
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Advances in experimental medicine and biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- NF-κB, PPARα, inflammation, inflammatory gene expression, IκBα, p65 phosphorylation, CBP/p300, histone H3 Ser10 phosphorylation, IL-6 promoter, chromatin, Sp1, transcriptional regulation, autoregulatory loop, glucocorticoids
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Inflammation, Models, Biological, Transcription Factors, Transcriptional Activation, Interleukin-6, NF-kappa B, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, MAP Kinase Signaling System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Paradigm for Gene Regulation: Inflammation, NF-κB and PPAR. https://app.cochat.ai/papers/10.1007/978-1-4419-9072-3_22
- The paper
- Vanden Berghe, W., Vermeulen, L., Delerive, P., De Bosscher, K., Staels, B., & Haegeman, G. (2003). A Paradigm for Gene Regulation: Inflammation, NF-κB and PPAR. Advances in experimental medicine and biology. https://doi.org/10.1007/978-1-4419-9072-3_22
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.